{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T11:54:07Z","timestamp":1777463647206,"version":"3.51.4"},"reference-count":100,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100010582","name":"National Computational Infrastructure","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010582","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001782","name":"University of Melbourne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001782","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular Graphics and Modelling"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.jmgm.2023.108602","type":"journal-article","created":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T05:29:55Z","timestamp":1692163795000},"page":"108602","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["EpiMed Coronabank Chemical Collection: Compound selection, ADMET analysis, and utilisation in the context of potential SARS-CoV-2 antivirals"],"prefix":"10.1016","volume":"125","author":[{"given":"Eleni","family":"Pitsillou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond C.","family":"Beh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia J.","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thinh Sieu","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya Yun","family":"Siow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinghao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zifang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zifei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Hung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom C.","family":"Karagiannis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmgm.2023.108602_bib1","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/S0140-6736(21)00503-1","article-title":"Urgent lessons from COVID 19: why the world needs a standing, coordinated system and sustainable financing for global research and development","volume":"397","author":"Lurie","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jmgm.2023.108602_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107930","article-title":"Drug repurposing for COVID-19: approaches, challenges and promising candidates","volume":"228","author":"Ng","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jmgm.2023.108602_bib3","volume":"2023","year":"2020"},{"key":"10.1016\/j.jmgm.2023.108602_bib4","first-page":"693","article-title":"Dexamethasone in hospitalized patients with covid-19","volume":"384","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jmgm.2023.108602_bib5","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s13578-021-00643-z","article-title":"SARS-CoV-2: from its discovery to genome structure, transcription, and replication","volume":"11","author":"Brant","year":"2021","journal-title":"Cell Biosci."},{"key":"10.1016\/j.jmgm.2023.108602_bib6","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12964-023-01104-5","article-title":"Structural and non-structural proteins in SARS-CoV-2: potential aspects to COVID-19 treatment or prevention of progression of related diseases","volume":"21","author":"Kakavandi","year":"2023","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.jmgm.2023.108602_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/v14091991","article-title":"SARS-CoV-2 non-structural proteins and their roles in host immune evasion","volume":"14","author":"Low","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.jmgm.2023.108602_bib8","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/cid\/ciac180","article-title":"Oral coronavirus disease 2019 antiviral drugs","volume":"76","author":"Saravolatz","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jmgm.2023.108602_bib9","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41467-020-20542-0","article-title":"Mechanism of SARS-CoV-2 polymerase stalling by remdesivir","volume":"12","author":"Kokic","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jmgm.2023.108602_bib10","article-title":"Contribution of SARS-CoV-2 accessory proteins to viral pathogenicity in K18 human ACE2 transgenic mice","volume":"95","author":"Silvas Jesus","year":"2021","journal-title":"J. Virol."},{"key":"10.1016\/j.jmgm.2023.108602_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113889","article-title":"The role of SARS-CoV-2 accessory proteins in immune evasion","volume":"156","author":"Zandi","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jmgm.2023.108602_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112443","article-title":"Enhanced evasion of neutralizing antibody response by Omicron XBB.1.5, CH.1.1, and CA.3.1 variants","volume":"42","author":"Qu","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.jmgm.2023.108602_bib13","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2217\/imt-2021-0168","article-title":"A global picture: therapeutic perspectives for COVID-19","volume":"14","author":"Chavda","year":"2022","journal-title":"Immunotherapy"},{"key":"10.1016\/j.jmgm.2023.108602_bib14","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41581-022-00642-4","article-title":"Therapeutic advances in COVID-19","volume":"19","author":"Murakami","year":"2023","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.jmgm.2023.108602_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28289","article-title":"Clinical trials on the pharmacological treatment of long COVID: a systematic review","volume":"95","author":"Chee","year":"2023","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.jmgm.2023.108602_bib16","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41579-022-00846-2","article-title":"Long COVID: major findings, mechanisms and recommendations","volume":"21","author":"Davis","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.jmgm.2023.108602_bib17","article-title":"Safety and efficacy of low dose naltrexone in a long covid cohort; an interventional pre-post study","volume":"24","author":"O'Kelly","year":"2022","journal-title":"Brain Behav Immun Health"},{"key":"10.1016\/j.jmgm.2023.108602_bib18","unstructured":"U.S. Food and Drug Administration. Drugs@FDA: FDA-Approved Drugs."},{"key":"10.1016\/j.jmgm.2023.108602_bib19","doi-asserted-by":"crossref","first-page":"D1373","DOI":"10.1093\/nar\/gkac956","article-title":"PubChem 2023 update","volume":"51","author":"Kim","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jmgm.2023.108602_bib20","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1021\/ed100697w","article-title":"An online chemical information resource","volume":"87","author":"Pence","year":"2010","journal-title":"J. Chem. Educ."},{"key":"10.1016\/j.jmgm.2023.108602_bib21","doi-asserted-by":"crossref","first-page":"D930","DOI":"10.1093\/nar\/gky1075","article-title":"ChEMBL: towards direct deposition of bioassay data","volume":"47","author":"Mendez","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jmgm.2023.108602_bib22","doi-asserted-by":"crossref","first-page":"W612","DOI":"10.1093\/nar\/gkv352","article-title":"ChEMBL web services: streamlining access to drug discovery data and utilities","volume":"43","author":"Davies","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jmgm.2023.108602_bib23","doi-asserted-by":"crossref","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","article-title":"DrugBank 5.0: a major update to the DrugBank database for 2018","volume":"46","author":"Wishart","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jmgm.2023.108602_bib24","doi-asserted-by":"crossref","first-page":"D1124","DOI":"10.1093\/nar\/gks1047","article-title":"NPACT: naturally occurring plant-based anti-cancer compound-activity-target database","volume":"41","author":"Mangal","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jmgm.2023.108602_bib25","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/978-1-4939-2269-7_19","article-title":"Small-molecule library screening by docking with PyRx","volume":"1263","author":"Dallakyan","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jmgm.2023.108602_bib26","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1758-2946-3-33","article-title":"Open Babel: an open chemical toolbox","volume":"3","author":"O'Boyle","year":"2011","journal-title":"J. Cheminf."},{"key":"10.1016\/j.jmgm.2023.108602_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jmgm.2023.108602_bib28","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkab255","article-title":"ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties","volume":"49","author":"Xiong","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jmgm.2023.108602_bib29","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1002\/minf.201500040","article-title":"Pred-hERG: a novel web-accessible computational tool for predicting cardiac toxicity","volume":"34","author":"Braga","year":"2015","journal-title":"Mol Inform"},{"key":"10.1016\/j.jmgm.2023.108602_bib30","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/s42003-021-01735-9","article-title":"Tipiracil binds to uridine site and inhibits Nsp15 endoribonuclease NendoU from SARS-CoV-2","volume":"4","author":"Kim","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/j.jmgm.2023.108602_bib31","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.jmb.2007.05.022","article-title":"Inference of macromolecular assemblies from crystalline state","volume":"372","author":"Krissinel","year":"2007","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jmgm.2023.108602_bib32","unstructured":"Protein Interfaces, Surfaces and Assemblies' service PISA at the European Bioinformatics Institute."},{"key":"10.1016\/j.jmgm.2023.108602_bib33","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/s41594-021-00570-0","article-title":"Structural basis for inhibition of the SARS-CoV-2 RNA polymerase by suramin","volume":"28","author":"Yin","year":"2021","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.jmgm.2023.108602_bib34","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/s41594-021-00619-0","article-title":"Cryo-EM structure of SARS-CoV-2 ORF3a in lipid nanodiscs","volume":"28","author":"Kern","year":"2021","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.jmgm.2023.108602_bib35","first-page":"8","article-title":"The PyMOL molecular graphics system","volume":"1","author":"Schrodinger","year":"2015","journal-title":"Versiones"},{"key":"10.1016\/j.jmgm.2023.108602_bib36","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jmgm.2023.108602_bib37","doi-asserted-by":"crossref","first-page":"W593","DOI":"10.1093\/nar\/gkac389","article-title":"PrankWeb 3: accelerated ligand-binding site predictions for experimental and modelled protein structures","volume":"50","author":"Jakubec","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jmgm.2023.108602_bib38","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jmgm.2023.108602_bib39","series-title":"Schr\u00f6dinger Release 2023-2","year":"2023"},{"key":"10.1016\/j.jmgm.2023.108602_bib40","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"VMD: visual molecular dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"J. Mol. Graph."},{"key":"10.1016\/j.jmgm.2023.108602_bib41","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/s41573-023-00672-y","article-title":"Therapeutic strategies for COVID-19: progress and lessons learned","volume":"22","author":"Li","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jmgm.2023.108602_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2020.00726","article-title":"Computational approaches in preclinical studies on drug discovery and development","volume":"8","author":"Wu","year":"2020","journal-title":"Front. Chem."},{"key":"10.1016\/j.jmgm.2023.108602_bib43","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s40262-021-00984-5","article-title":"Pharmacokinetic, pharmacodynamic, and drug-interaction profile of remdesivir, a SARS-CoV-2 replication inhibitor","volume":"60","author":"Humeniuk","year":"2021","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.jmgm.2023.108602_bib44","doi-asserted-by":"crossref","first-page":"295","DOI":"10.4155\/fmc.13.202","article-title":"Predictive in silico off-target profiling in drug discovery","volume":"6","author":"Schmidt","year":"2014","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.jmgm.2023.108602_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112290","article-title":"hERG toxicity assessment: useful guidelines for drug design","volume":"195","author":"Garrido","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jmgm.2023.108602_bib46","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/med.21445","article-title":"Development of safe drugs: the hERG challenge","volume":"38","author":"Kalyaanamoorthy","year":"2018","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.jmgm.2023.108602_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2022.105247","article-title":"Identification of novel bioactive compounds from Olea europaea by evaluation of chemical compounds in the OliveNet\u2122 library: in silico bioactivity and molecular modelling, and in vitro validation of hERG activity","volume":"142","author":"Pitsillou","year":"2022","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.jmgm.2023.108602_bib48","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2165\/00003495-198938010-00003","volume":"38","author":"McTavish","year":"1989","journal-title":"Verapamil. Drugs."},{"key":"10.1016\/j.jmgm.2023.108602_bib49","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1526-4610.2008.01298.x","article-title":"Tfelt-hansen, J. Verapamil for cluster headache. Clinical pharmacology and possible mode of action","volume":"49","author":"Tfelt-Hansen","year":"2009","journal-title":"Headache J. Head Face Pain"},{"key":"10.1016\/j.jmgm.2023.108602_bib50","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1161\/01.RES.84.9.989","article-title":"Mechanism of block and identification of the verapamil binding domain to HERG potassium channels","volume":"84","author":"Zhang","year":"1999","journal-title":"Circ. Res."},{"key":"10.1016\/j.jmgm.2023.108602_bib51","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/ijc.2910560523","article-title":"Verapamil decreases P-glycoprotein expression in multidrug-resistant human leukemic cell lines","volume":"56","author":"Muller","year":"1994","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jmgm.2023.108602_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122004","article-title":"The Caco-2 Model: modifications and enhancements to improve efficiency and predictive performance","volume":"624","author":"Panse","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jmgm.2023.108602_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0190319","article-title":"Predicting apparent passive permeability of Caco-2 and MDCK cell-monolayers: a mechanistic model","volume":"12","author":"Bittermann","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jmgm.2023.108602_bib54","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/j.apsb.2021.03.028","article-title":"Can remdesivir and its parent nucleoside GS-441524 be potential oral drugs? An in vitro and in vivo DMPK assessment","volume":"11","author":"Xie","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jmgm.2023.108602_bib55","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1021\/acs.jmedchem.6b01594","article-title":"Discovery and synthesis of a phosphoramidate prodrug of a pyrrolo[2,1-f][triazin-4-amino] adenine C-nucleoside (GS-5734) for the treatment of Ebola and emerging viruses","volume":"60","author":"Siegel","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmgm.2023.108602_bib56","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1038\/s41596-018-0066-x","article-title":"Blood-brain-barrier organoids for investigating the permeability of CNS therapeutics","volume":"13","author":"Bergmann","year":"2018","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jmgm.2023.108602_bib57","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23073812","article-title":"Potential role of the antidepressants fluoxetine and fluvoxamine in the treatment of COVID-19","volume":"23","author":"Mahdi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jmgm.2023.108602_bib58","doi-asserted-by":"crossref","first-page":"8238","DOI":"10.1021\/jm5007935","article-title":"Rational use of plasma protein and tissue binding data in drug design","volume":"57","author":"Liu","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmgm.2023.108602_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2014.11.013","article-title":"Modulation of P-glycoprotein efflux pump: induction and activation as a therapeutic strategy","volume":"149","author":"Silva","year":"2015","journal-title":"Pharmacol. Therapeut."},{"key":"10.1016\/j.jmgm.2023.108602_bib60","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.lfs.2018.10.048","article-title":"Structural and functional aspects of P-glycoprotein and its inhibitors","volume":"214","author":"Mollazadeh","year":"2018","journal-title":"Life Sci."},{"key":"10.1016\/j.jmgm.2023.108602_bib61","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.576559","article-title":"One mechanism, many tasks and the consequences for pharmacotherapy of cancers","volume":"10","author":"Seelig","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jmgm.2023.108602_bib62","volume":"2023","year":"2022"},{"key":"10.1016\/j.jmgm.2023.108602_bib63","doi-asserted-by":"crossref","first-page":"18422","DOI":"10.1073\/pnas.1010693107","article-title":"Structure and mechanism of the complex between cytochrome P4503A4 and ritonavir","volume":"107","author":"Sevrioukova","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jmgm.2023.108602_bib64","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s40262-022-01158-7","article-title":"Yes we can (use nirmatrelvir\/ritonavir even in high immunological risk patients treated with immunosuppressive drugs)","volume":"61","author":"Lemaitre","year":"2022","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.jmgm.2023.108602_bib65","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0140-6736(20)32013-4","article-title":"Lopinavir-ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial","volume":"396","author":"Horby","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jmgm.2023.108602_bib66","first-page":"22","article-title":"Cytochrome P450 enzymes and drug metabolism in humans","author":"Zhao","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jmgm.2023.108602_bib67","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12090846","article-title":"Mechanisms of CYP450 inhibition: understanding drug-drug interactions due to mechanism-based inhibition in clinical practice","volume":"12","author":"Deodhar","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jmgm.2023.108602_bib68","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1007\/s00204-020-02936-7","article-title":"Inhibition and induction of CYP enzymes in humans: an update","volume":"94","author":"Hakkola","year":"2020","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.jmgm.2023.108602_bib69","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1136\/thoraxjnl-2020-216243","article-title":"COVID-19, immunothrombosis and venous thromboembolism: biological mechanisms","volume":"76","author":"Joan","year":"2021","journal-title":"Thorax"},{"key":"10.1016\/j.jmgm.2023.108602_bib70","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1177\/10600280211025042","article-title":"Potential dexamethasone\u2013direct oral anticoagulant drug interaction: is this a concern in COVID?","volume":"56","author":"Smythe","year":"2021","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.jmgm.2023.108602_bib71","first-page":"473","article-title":"Drug-Induced QT prolongation and Torsades de Pointes","volume":"42","author":"Li","year":"2017","journal-title":"P T"},{"key":"10.1016\/j.jmgm.2023.108602_bib72","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1016\/j.drudis.2022.04.001","article-title":"Repurposing drugs as COVID-19 therapies: a toxicity evaluation","volume":"27","author":"Ngan","year":"2022","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jmgm.2023.108602_bib73","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1124\/jpet.120.000484","article-title":"COVID-19 drugs chloroquine and hydroxychloroquine, but not azithromycin and remdesivir, block hERG potassium channels","volume":"377","author":"Mark","year":"2021","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.jmgm.2023.108602_bib74","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/S0140-6736(05)17950-1","article-title":"Blockade of HERG channels by HIV protease inhibitors","volume":"365","author":"Anson","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jmgm.2023.108602_bib75","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1126\/science.abb7498","article-title":"Structure of the RNA-dependent RNA polymerase from COVID-19 virus","volume":"368","author":"Gao","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jmgm.2023.108602_bib76","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.coviro.2021.03.010","article-title":"Structure and function of SARS-CoV-2 polymerase","volume":"48","author":"Hillen","year":"2021","journal-title":"Current Opinion in Virology"},{"key":"10.1016\/j.jmgm.2023.108602_bib77","first-page":"59","article-title":"Chapter three - the nonstructural proteins directing coronavirus RNA synthesis and processing","volume":"96","author":"Snijder","year":"2016"},{"key":"10.1016\/j.jmgm.2023.108602_bib78","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s15010-020-01557-7","article-title":"Remdesivir in Coronavirus Disease 2019 (COVID-19) treatment: a review of evidence","volume":"49","author":"Lin","year":"2021","journal-title":"Infection"},{"key":"10.1016\/j.jmgm.2023.108602_bib79","doi-asserted-by":"crossref","DOI":"10.7573\/dic.2020-4-14","article-title":"The journey of remdesivir: from Ebola to COVID-19","volume":"9","author":"Pardo","year":"2020","journal-title":"Drugs Context"},{"key":"10.1016\/j.jmgm.2023.108602_bib80","doi-asserted-by":"crossref","first-page":"e516","DOI":"10.1093\/cid\/ciab1035","article-title":"Real-World effectiveness of remdesivir in adults hospitalized with coronavirus disease 2019 (COVID-19): a retrospective, multicenter comparative effectiveness study","volume":"75","author":"Garibaldi","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jmgm.2023.108602_bib81","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/s41594-021-00651-0","article-title":"Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis","volume":"28","author":"Kabinger","year":"2021","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.jmgm.2023.108602_bib82","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1056\/NEJMoa2116846","article-title":"Early remdesivir to prevent progression to severe covid-19 in outpatients","volume":"386","author":"Gottlieb","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jmgm.2023.108602_bib83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-021-07004-8","article-title":"Safety and clinical outcomes of remdesivir in hospitalised COVID-19 patients: a retrospective analysis of active surveillance database","volume":"22","author":"Gupte","year":"2022","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.jmgm.2023.108602_bib84","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/S0140-6736(22)00519-0","article-title":"Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses","volume":"399","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jmgm.2023.108602_bib85","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/s41586-020-2368-8","article-title":"Structure of replicating SARS-CoV-2 polymerase","volume":"584","author":"Hillen","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jmgm.2023.108602_bib86","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00900-20","article-title":"Suramin inhibits SARS-CoV-2 infection in cell culture by interfering with early steps of the replication cycle","volume":"64","author":"Salgado-Benvindo","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jmgm.2023.108602_bib87","first-page":"244","article-title":"Suramin in the treatment of onchocerciasis: the efficacy of low doses on the parasite in an area with vector control","volume":"36","author":"Schulz-Key","year":"1985","journal-title":"Trop. Med. Parasitol."},{"key":"10.1016\/j.jmgm.2023.108602_bib88","first-page":"64","article-title":"100 Years of suramin","author":"Wiedemar","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jmgm.2023.108602_bib89","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/j.1552-4604.1986.tb02897.x","article-title":"Clinical pharmacokinetics of suramin in patients with HTLV-III\/LAV infection","volume":"26","author":"Collins","year":"1986","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.jmgm.2023.108602_bib90","first-page":"142","article-title":"Viekira pak (ombitasvir, paritaprevir, and ritonavir tablets; dasabuvir tablets): all-oral fixed combination approved for genotype 1 chronic hepatitis C infection","volume":"8","author":"Raedler","year":"2015","journal-title":"Am Health Drug Benefits"},{"key":"10.1016\/j.jmgm.2023.108602_bib91","doi-asserted-by":"crossref","first-page":"8094","DOI":"10.1073\/pnas.1921485117","article-title":"Coronavirus endoribonuclease targets viral polyuridine sequences to evade activating host sensors","volume":"117","author":"Hackbart","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jmgm.2023.108602_bib92","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1002\/pro.3873","article-title":"Crystal structure of Nsp15 endoribonuclease NendoU from SARS-CoV-2","volume":"29","author":"Kim","year":"2020","journal-title":"Protein Sci."},{"key":"10.1016\/j.jmgm.2023.108602_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.132488","article-title":"Identification of SARS-CoV-2 surface therapeutic targets and drugs using molecular modeling methods for inhibition of the virus entry","volume":"1256","author":"Farhadian","year":"2022","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.jmgm.2023.108602_bib94","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.647693","article-title":"Combining SARS-CoV-2 proofreading exonuclease and RNA-dependent RNA polymerase inhibitors as a strategy to combat COVID-19: a high-throughput in silico screening","volume":"12","author":"Khater","year":"2021","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.jmgm.2023.108602_bib95","first-page":"13","article-title":"Understanding the role of SARS-CoV-2 ORF3a in viral pathogenesis and COVID-19","author":"Zhang","year":"2022","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.jmgm.2023.108602_bib96","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.1016\/j.devcel.2021.10.006","article-title":"ORF3a of SARS-CoV-2 promotes lysosomal exocytosis-mediated viral egress","volume":"56","author":"Chen","year":"2021","journal-title":"Dev. Cell"},{"key":"10.1016\/j.jmgm.2023.108602_bib97","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.84477","article-title":"The SARS-CoV-2 accessory protein Orf3a is not an ion channel, but does interact with trafficking proteins","volume":"12","author":"Miller","year":"2023","journal-title":"Elife"},{"key":"10.1016\/j.jmgm.2023.108602_bib98","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2208525120","article-title":"SARS-CoV-2 accessory proteins ORF7a and ORF3a use distinct mechanisms to down-regulate MHC-I surface expression","volume":"120","author":"Arshad","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jmgm.2023.108602_bib99","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.antiviral.2011.02.008","article-title":"Emodin inhibits current through SARS-associated coronavirus 3a protein","volume":"90","author":"Schwarz","year":"2011","journal-title":"Antivir. Res."},{"key":"10.1016\/j.jmgm.2023.108602_bib100","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1055\/s-0033-1360277","article-title":"Kaempferol derivatives as antiviral drugs against the 3a channel protein of coronavirus","volume":"80","author":"Schwarz","year":"2014","journal-title":"Planta Med."}],"container-title":["Journal of Molecular Graphics and Modelling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326323002000?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326323002000?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T21:15:52Z","timestamp":1761081352000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1093326323002000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":100,"alternative-id":["S1093326323002000"],"URL":"https:\/\/doi.org\/10.1016\/j.jmgm.2023.108602","relation":{},"ISSN":["1093-3263"],"issn-type":[{"value":"1093-3263","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"EpiMed Coronabank Chemical Collection: Compound selection, ADMET analysis, and utilisation in the context of potential SARS-CoV-2 antivirals","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular Graphics and Modelling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmgm.2023.108602","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108602"}}